Rheumatology

Latest News

FDA approves tocilizumab-anoh for CRS in patients 2 years and older | Image credit: Contemporary Pediatrics
FDA approves tocilizumab-anoh for CRS in patients 2 years and older

August 6th 2025

The expanded label of tocilizumab-anoh now includes treatment for patients aged 2 years and older with cytokine release syndrome (CRS).

Marstacimab reduces ABR in patients 12 years and up with hemophilia A or B with inhibitors | Image Credit: © lexiconimages - © lexiconimages - stock.adobe.com.
Marstacimab reduces ABR in patients 12 years and up with hemophilia A or B with inhibitors

June 26th 2025

FDA will not meet original PDUFA data for sebetralstat to treat HAE | Image Credit: Contemporary Pediatrics
FDA will not meet original PDUFA date for sebetralstat to treat HAE

June 16th 2025

Positive data: Navepegritide, lonapegsomatropin combination treatment for children with achondroplasia | Image Credit: © lexiconimages - © lexiconimages - stock.adobe.com.
Positive data: Navepegritide, lonapegsomatropin combination treatment for children with achondroplasia

June 9th 2025

FDA accepts navepegritide application to treat children with achondroplasia | Image credit: Contemporary Pediatrics
FDA accepts navepegritide application to treat children with achondroplasia

June 2nd 2025

Latest CME Events & Activities
<12
© 2025 MJH Life Sciences

All rights reserved.